Alphina Therapeutics
PrivateLast Round
Seed Round
Mar 16, 2026
Total Funding Raised
$40M
Momentum Score
25 /100
Company Overview
Alphina Therapeutics is a biotechnology company focused on developing innovative small molecules that target various nodes in NAD synthesis pathways to create selective tumor-targeting therapies and biomarkers for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphina Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Alphina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 16, 2026 | ||||
| Series A | Sep 7, 2021 | ||||
| Pre Seed | Dec 15, 2020 |
Key People
Founding team and executive leadership
Alphina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed |
| HighCape Capital | Pre Seed |
| Osage University Partners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 48% month-over-month.
Alphina Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alphina Therapeutics's valuation, stock price, and market status.
